Patent Covers Three Main Methods of Associating Nanoparticles with Filter Media

Applied Nanoscience Inc., a nanotechnology-based filtration development company, today announced that it has been issued a patent in New Zealand for its core technology platform encompassing "Filtering Devices Incorporating Nanoparticles." The patent covers three main methods of associating nanoparticles with filter media: (1) having pellets of nanoparticles located adjacent to the filter media; (2) coating the filter media with a powder of nanoparticles; and, (3) impregnating the nanoparticles into the filter media.

In addition, ANI has been informed by its attorneys in Australia that a patent for this same invention will issue as a matter of course within 90 days. The patent became sealed on July 17 and will afford broad protection for filtration applications across all of Australia.

"We continue to build momentum in securing key foreign protection for our core technology platform. This recent progress, combined with our proprietary silver nanoparticle formulation (NanoFense™) should become a very attractive consideration to established filtration-based companies in some of the more populated parts of the world," said Thomas K. Allen, President and CEO, ANI.

ANI has also received patents on its platform technology in Russia, Singapore, Taiwan and India.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.